Kymera Therapeutics Announces Positive Interim Results from Single Ascending Dose Phase 1 Trial of KT-474 Demonstrating Degrader Proof-of-Mechanism

Frank Burrell
Scientific Storytelling

Bud Bilanich
Success Coach

Liz Kane
Impactful Strategy

Matthew Durham
Omnidynamic Marketing

Pat Purcell
Meeting Engagement

Suma Ramadas, PhD
Medical Affairs

Stacey Gandler
Brand Nourishment

Matt Turner
Patient Affordability

Paul Theisen
Patient Acquisition

David Linetsky
Point-of-Care Marketing

Brenda Snow
Authentic Patient Voice

Joey Cohen
Medication Adherence

Amy Giles
Increasing Engagement

Daniel Sontupe
Market Access